![]() |
![]()
Daily COVID-19 News
Alert
Here is a summary of
recent Centers for Medicare & Medicaid Services (CMS) actions taken in
response to the 2019 Novel Coronavirus (COVID-19), as part of the ongoing
White House Task Force efforts. To keep up with the important work the Task
Force is doing in response to COVID-19, click here www.coronavirus.gov. For information
specific to CMS, please visit the CMS News Room and Current Emergencies Website. CMS updates
these resources on an ongoing basis throughout the day; the information below
is current as of April 16, 2020 at 10:15 a.m. ET.
COVID-19 Call: Audio
Recording and Transcript
An audio recording and transcript are available for the April 7 Medicare Learning Network call on
2019 Novel Coronavirus (COVID-19) Updates. Learn about CMS waivers and
COVID-19 response.
CMS Increases
Medicare Payment for High-Production Coronavirus Lab Tests
CMS announced that
Medicare will nearly double payment for certain lab tests that use
high-throughput technologies to rapidly diagnose large numbers of COVID-19
cases. This is another action the Trump Administration is taking to rapidly
expand COVID-19 testing. Along with the March 30 announcement that Medicare
will pay new specimen collection fees for COVID-19 testing, CMS’s actions
will expand capability to test more vulnerable populations, like nursing home
patients, quickly and provide results faster. Medicare will pay laboratories
for the tests at $100 effective April 14, 2020, through the duration of the
COVID-19 national emergency.
CMS Implements CARES
Act Hospital Payment and Inpatient Rehabilitation Facility Waivers
The Coronavirus Aid,
Relief, and Economic Security (CARES) Act increases payment for Inpatient
Prospective Payment System (IPPS) and long-term care hospital (LTCH)
inpatient hospital care attributable to COVID-19. CMS provided guidance for
IPPS hospitals and LTCHs on how to code claims to receive the higher payment.
The CARES Act also waives
the requirement that Medicare Part A fee-for-service patients treated in
inpatient rehabilitation facilities receive at least 15 hours of therapy per
week.
CMS Approves
Additional State Medicaid Waivers and Amendments to Give States Flexibility
to Address Coronavirus Pandemic
CMS has approved 52 COVID-
related emergency waivers, 31 state amendments, 11 COVID-related Medicaid
Disaster Amendments and one CHIP COVID-related Disaster Amendment in record
time. States are using a toolkit CMS developed to expedite the
application and approval of Medicaid state waivers and State Plan
Amendments.
CMS recently approved two
additional COVID-related emergency Medicaid waivers, delivering urgent
regulatory relief to ensure the Commonwealth of Puerto Rico and the
Commonwealth of the Northern Mariana Islands can quickly and effectively care
for their most vulnerable citizens. CMS also approved COVID-related Medicaid
Disaster Amendments that bring relief to Arkansas and Rhode Island. These
approvals help to ensure that states have the tools they need to combat
COVID-19 through a wide variety of state plan flexibilities. CMS
continues to authorize amendments to ensure emergency flexibilities in
programs that care for the elderly and people with disabilities, including
most recently for Colorado, Louisiana and Nevada. These approved
flexibilities support President Trump’s commitment to a COVID-19 response
that is locally executed, state managed, and federally supported.
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Thursday, April 16, 2020
Daily COVID-19 CMS News Alert
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment